Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Mayo-Designed Nonmetallic, Ultrasound-Detectable Marker for Metastatic Axillary Lymph Nodes in Breast Cancer

NCT04674852 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04674852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04674852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Mayo-Designed Nonmetallic, Ultrasound-Detectable Marker for Metastatic Axillary Lymph Nodes in Breast Cancer
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
November 2, 2020
Completion date
April 7, 2022
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm female, ultrasound therapy; complications